Thermo Fisher Scientific (China): difference between revisions
Diff·revision 12 → 13·18:00, 26 Jul 2026
Difference between revision 12 and revision 13 of Thermo Fisher Scientific (China). 3 lines changed; the page grew by 1,121 bytes.
| Revision 12 — 18:00, 26 Jul 2026 SecondarySrc_Seb (talk) add the standing talk-page note link to the banner 8,850 bytes +144 | Revision 13 — 18:00, 26 Jul 2026 Chromatokid (talk) add the outbound storefront link, marked nofollow and sponsored per the external-links convention 9,971 bytes +1,121 | ||
|---|---|---|---|
| 51 | | Raw materials | Bulk powders | Certificate with purity; specification stated at 98 per cent | | 51 | | Raw materials | Bulk powders | Certificate with purity; specification stated at 98 per cent | |
| 52 | 52 | ||
| + | 53 | == Independent testing record == | |
| + | 54 | Reports on TFS material submitted to PeptidePedia in 2026 cover the incretin analogues most heavily, with a smaller set on repair peptides and a handful on bulk raw material. Reported [[Area percent purity|area percent]] figures have been high across the set, and in every submission on file the reported figure has been at or above the stated release specification rather than below it.{{r|reports}} Where two services examined the same lot, reported figures differed by a few tenths of a point, which is consistent with method repeatability rather than with disagreement.{{r|reports}} Four submissions instead compare two successive lots of one catalogue line, using the retained certificate; those differences fall in the same range, which supports a statement about the two lots examined and does not support one about the catalogue.{{r|reports}} The submitted set is self-selected and covers a small fraction of the listed catalogue; nothing here supports a statement about lines nobody has submitted, and the oral-tablet lines in particular are represented by a single submission. | |
| + | 55 | ||
| 53 | == References == | 56 | == References == |
| 54 | {{reflist}} | 57 | {{reflist}} |